V. Calvo-Río

Anti–Interleukin‐6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty‐Five Patients

V. Calvo-Río, Inmaculada Calvo, María Isabel González et al. · Arthritis & Rheumatology · 2016 · 152 citations

Medicine, Ophthalmology, Pharmacotherapy +17

Efficacy of Tocilizumab in Conventional Treatment–Refractory Adult‐Onset Still's Disease: Multicenter Retrospective Open‐Label Study of Thirty‐Four Patients

F. Ortíz-Sanjuán, Ricardo Blanco, V. Calvo-Río et al. · Arthritis & Rheumatology · 2014 · 143 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +10

Henoch-Schönlein Purpura in Northern Spain

V. Calvo-Río, J. Loricera, Cristina Mata et al. · Medicine · 2014 · 138 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +9

Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients

J. Loricera, Ricardo Blanco, José L. Hernández et al. · Seminars in Arthritis and Rheumatism · 2014 · 134 citations · Full text

Life Sciences, Surgery, Immunotherapy +6

Anti-TNF-  therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients

V. Calvo-Río, Ricardo Blanco, E. Beltrán et al. · Lara D. Veeken · 2014 · 123 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17